Michael Klichinsky is Chief Scientific Officer of Sesen Bio, Inc.. Currently has a direct ownership of 0 shares of SESN, which is worth approximately $0. The most recent transaction as insider was on Oct 07, 2025, when has been sold 56,982 shares (Common Stock) at a price of $0.25 per share, resulting in proceeds of $14,245. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
100.0% 3M change
100.0% 12M change
Total Value Held $0

Michael Klichinsky Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 07 2025
SELL
Open market or private sale
$14,245 $0.25 p/Share
56,982 Reduced 100.0%
0 Common Stock
Oct 07 2025
BUY
Exercise of conversion of derivative security
$6,268 $0.11 p/Share
56,982 Added 50.0%
56,982 Common Stock
Oct 03 2025
SELL
Open market or private sale
$31,030 $0.26 p/Share
119,347 Reduced 100.0%
0 Common Stock
Oct 02 2025
SELL
Open market or private sale
$50,000 $0.25 p/Share
200,000 Reduced 62.63%
119,347 Common Stock
Oct 01 2025
SELL
Open market or private sale
$42,900 $0.26 p/Share
165,000 Reduced 34.07%
319,347 Common Stock
Mar 07 2023
BUY
Grant, award, or other acquisition
-
484,347 Added 50.0%
484,347 Common Stock
MK

Michael Klichinsky

Chief Scientific Officer
Philadelphia, PA

Track Institutional and Insider Activities on SESN

Follow Sesen Bio, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SESN shares.

Notify only if

Insider Trading

Get notified when an Sesen Bio, Inc. insider buys or sells SESN shares.

Notify only if

News

Receive news related to Sesen Bio, Inc.

Track Activities on SESN